Ress Life Investments A/S
Ress Life Investments A/S, Decisions of the extraordinary general meeting held on 24 October 2025
Ress Life Investments A/S, Decisions of the extraordinary general meeting held on 24 October 2025
Ress Life Investments A/S
Nybrogade 12
DK-1203 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 24 October 2025
Corporate Announcement 33/2025
Ress Life Investments A/S announces the events of the extraordinary general meeting held on 24 October 2025.
At the extraordinary general meeting of Ress Life Investments A/S held on Friday 24 October 2025, the following decision was taken:
- Decrease of the company's share capital by EUR 30,000,000 by cancellation of 60,000 treasury shares was approved - cf item 1 of the agenda.
Questions related to this announcement can be made to the company’s AIF-manager, Resscapital AB.
Contact person:
Gustaf Hagerud
gustaf.hagerud@resscapital.com
Tel + 46 8 545 282 27
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.24.10.2025 13:30:44 CEST | Press release
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
The Government of Gangnan District, Guigang City24.10.2025 13:06:07 CEST | Press release
Gangnan District, Guigang City, Guangxi: Building a Wood-Based Smart Home Industry Cluster Facing ASEAN
Sveriges Riksbank24.10.2025 10:07:39 CEST | Press release
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
Marimekko Corporation24.10.2025 10:00:00 CEST | Press release
Release of Marimekko's Interim Report, 1 January–30 September 2025
Polpharma Group24.10.2025 09:51:33 CEST | Press release
Polpharma Group Announces Leadership Transition – Sebastian Szymanek appointed as its new President
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom